Our study showed that shorter (GT)n repeat in the HO-1 gene promoter were associated with a lower Jeopardy severity score in patients with significant CAD.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: